Yongjie Wu

2019-01-09 T |T
Name: Yongjie Wu
Professional Title:Professor
E-mail: wuyj@lzu.edu.cn
Research Interests: Antitumor Pharmacology; Preclinical Pharmacology of New Drugs and Anti-inflammatory Pharmacology
 
Education/Training: 
1984  Shanxi Medical College  M.S. in Pharmacology
1999  Lanzhou Medical College  Student in Clinical Medicine
 
Awards&Honors:
1.    1992  obtained the honor of The Young Teachers Chengcai Award in Gansu Province;
2.    1998  obtained the honor of Academic technology leaders of Gansu Province;
3.    2006  obtaine the second prize of Gansu Provincial Science and Technology Progress Award (First author) for Sdudy on Enteral delivery systems of Proanthocyanidin from Grape Seeds;
4.    2006  obtained the second prize of Gansu Provincial Natural Science (Third author) for the Mechanisms of Proanthocyanidin from Grape Seeds in both Potentiating Anti-tumor Activity and Reducing Toxicity of Doxorubicin;
5.    2006   obtained the honor of special allowance of Government of the State Council。
 
Projects: 
National Natural Science Foundation of China, 30672490, 2007.01-2009.12
 
Publications:
1.    Cui MX, Yang LN, Wang  XX, Wang L, Li RL, Han W, Wu YJ*. Alleviative effect of ciliary neurotrophic factor analogue on high fat-induced hepatic steatosis is partially independent of the central regulation. Clin Exp Pharmacol Physiol. 2017; 44:395–402.
2.    Cui MX, Jiang JJ, Min GN, Han W, and Wu YJ*. Ciliary Neurotrophic Factor Analogue Aggravates CCl4-induced Acute Hepatic Injury in Rats. Canadian Journal of Physiology and Pharmacology. 2017;95:620–623.
3.    Wan Li, Qi-Long Wang, Xia Liu, Shu-Hong Dong, Hong-Xia Li, Chun-Yang Li,Li-Shu Guo, Jing-Miao Gao, Nathan A. Berger, Li Li, Lan Ma, and Yong-Jie Wu*. Synergistic Chemopreventive Effects on Colorectal Neoplasia in Rats and Mice. Cancer. Prev. Res, 2015,8(2):139-148
4.    Baolai Zhang1,*, Shuhong Dong1, Zhongxin Li, Li Lu, Su Zhang, Xue Chen, Xiaobo Cen, and Yongjie Wu*. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta?catenin. Journal of Translational Medicine, 2015, 13:394.
5.    Li-Shu Guo, Hong-Xia Li, Chun-Yang Li, Sheng-Yan Zhang, Jia Chen, Qi-Long Wang, Jing-Miao Gao, Jia-Qi Liang,Ming-Tang Gao, Yong-Jie Wu* Synergistic antitumor activity of vitamin D3 combined with metformin in human breast carcinoma MDA-MB-231 cells involves m-TOR related signaling pathways. Pharmazie 2015,70: 117–122
6.    Li-Shu Guo, Hong-Xia Li, Chun-Yang Li, Sheng-Yan Zhang, Jia Chen, Qi-Long Wang, Jing-Miao Gao, Jia-Qi Liang,Ming-Tang Gao, Yong-Jie Wu* Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells. Pharmazie 2015.70: 123–128
7.    Hong-Xia Li, Jing-Miao Gao, Jia-Qi Liang, Jun-Min Xi, Meng Fu and Yong-Jie Wu*  Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway. Clinical and Experimental Pharmacology and Physiology 2015,42:711–717
8.    National invention patent  ZL200810208119.2, 2013.02.18
9.    National invention patent  ZL200810033775.3, 2012.05.16
10.National invention patent  ZL200610025335.4, 2011.01.12